Inventor · disambiguated record
Brent Chandler
Also filed as: CHANDLER BRENT · CHANDLER BRENT A
10 granted patents·5 pending applications·78 citations·filing 2004–2022
87Inventor score
Files withFORMFREE HOLDINGS CORP5DIXON JULIE A4BAYER PHARMACEUTICALS CORP2BAYER HEALTHCARE LLC1CHANDLER BRENT A1
Top patents by PatentIndex Score
15 records- 0189US8762243B2Systems and methods for electronic account certification and enhanced credit reportingJENKINS CHAD G·Filed 2012·Granted Jun 24, 2014·48 cites·18 claims
- 0288US7563791B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER PHARMACEUTICALS CORP·Filed 2005·Granted Jul 21, 2009·14 cites·8 claims
- 0379US8143393B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2006·Granted Mar 27, 2012·5 cites·11 claims
- 0478US8129379B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Mar 6, 2012·4 cites·2 claims
- 0576US10769723B2Systems and methods for electronic account certification and enhanced credit reportingFORMFREE HOLDINGS CORP·Filed 2017·Granted Sep 8, 2020·1 cites·9 claims
- 0672US8133995B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE·Filed 2006·Granted Mar 13, 2012·4 cites·13 claims
- 0771US8829185B2Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2012·Granted Sep 9, 2014·2 cites·5 claims
- 0868US2015228016A1Systems and methods for electronic account certification and enhanced credit reportingCHANDLER BRENT A·Filed 2014·Application pending·0 cites
- 0968US2021224902A1Systems and methods for electronic account certification and enhanced credit reportingFORMFREE HOLDINGS CORP·Filed 2021·Application pending·0 cites
- 1067US11989775B2Systems and methods for electronic account certification and enhanced credit reportingFORMFREE HOLDINGS CORP·Filed 2020·Granted May 21, 2024·0 cites·13 claims
- 1162US8338595B2Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisDIXON JULIE A·Filed 2009·Granted Dec 25, 2012·0 cites·8 claims
- 1258US2016343075A1Systems and methods for electronic account certification and enhanced credit reportingFORMFREE HOLDINGS CORP·Filed 2016·Application pending·0 cites
- 1353US2013225809A1Pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesisBAYER HEALTHCARE LLC·Filed 2012·Application pending·0 cites
- 1446US7238701B2Substituted tetrahydrobenzothienopyrimidinamine compounds useful for treating hyper-proliferative disordersBAYER PHARMACEUTICALS CORP·Filed 2004·Granted Jul 3, 2007·0 cites·7 claims
- 1545US2023186404A1Method and System for Classifying Financial TransactionsFORMFREE HOLDINGS CORP·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →